Latest news with #Anlene
Free Malaysia Today
4 days ago
- Business
- Free Malaysia Today
Sastera perjalanan sebagai satu genre
How TNB is transforming rural communities Tenaga Nasional Berhad's rural electrification programme is improving lives, boosting economies and bridging the digital divide. Batik Air launches its first international route from Subang Batik Air will operate daily flights to Bangkok Don Mueang International Airport beginning July 28, 2025. Anlene CholestoPro lowers cholesterol and supports bone health The new milk formulation is designed to support cholesterol levels while promoting bone, joint and muscle health. Turnover XXV sets the scene for a cinematic shake-up The new British film company lands in Malaysia with a plan to tell untold stories, train new talent, and flip the script on traditional filmmaking. Does your short horror film make the 'CUT!'? Win up to RM40,000! Sinister scares take the spotlight in Ampersand Advisory's thrilling new competition, which seeks scary movies of superior substance.
Free Malaysia Today
23-05-2025
- Health
- Free Malaysia Today
Anlene CholestoPro lowers cholesterol and supports bone health
Anlene hopes to raise awareness on routine screenings and lifestyle changes with the launch of CholestoPro. (Anlene pic) PETALING JAYA : One in three Malaysians has high cholesterol, but many remain unaware as the condition presents no early symptoms. This has earned cholesterol a reputation as a silent killer linked to heart attacks and strokes. Despite rising health concerns, awareness of routine screenings and lifestyle changes remains low, especially among those aged 35 and above. To address this, Anlene has introduced CholestoPro, a new adult milk with a dual action formula designed to support cholesterol levels while promoting bone, joint and muscle health. Anlene CholestoPro is designed to combat rising health concerns among Malaysian adults. (Anlene pic) Each two-serving intake contains 1.2g of plant sterols, proven effective to help lower cholesterol. The product also provides the 100% recommended daily intake of calcium and vitamin D, alongside protein, collagen and vitamin C. Anlene hopes the new formula will encourage more adults to take charge of their heart and mobility health before problems arise. Join Anlene's nationwide roadshow from now to July 2025. (Anlene pic) As part of the launch, a nationwide roadshow is running from now until July 2025, with free cholesterol checks, bone scans and muscle strength tests at selected locations. Anlene also highlights the importance of a balanced diet and active lifestyle in managing cholesterol and maintaining overall health. More information is available at Anlene's website. This article originally appeared on Berita Harian, with rights to be republished on Free Malaysia Today.
New Straits Times
23-05-2025
- Health
- New Straits Times
Anlene CholestoPro offers dual action formula, supporting cholesterol levels & mobility
KUALA LUMPUR: Nearly one in three Malaysians suffers from high cholesterol, but more than half remain unaware due to the absence of early symptoms, making it one of the country's leading 'silent killers' linked to heart attacks and strokes. Despite the growing health concern, awareness of routine health screenings and lifestyle changes remains low, particularly among those aged 35 and above. In response, Anlene has launched Anlene CholestoPro, a new milk formulation with a dual-action blend of nutrients designed to support both optimal cholesterol levels and mobility, which includes bone, joint and muscle health. The product contains 1.2 grams of plant sterols in two daily servings, clinically proven to help reduce cholesterol. It also provides 100 per cent of the recommended daily intake of calcium and vitamin D, along with protein, collagen and vitamin C to support overall movement and wellness. Anlene said the new product encourages a proactive approach to health, particularly for adults at higher risk of cardiovascular issues. NATIONWIDE ROADSHOW In conjunction with the launch, Anlene is conducting a nationwide health roadshow at selected locations until July. Members of the public can undergo free cholesterol checks, bone scans and muscle strength assessments to better understand their health status. A combination of a balanced diet and an active lifestyle remains the most effective strategy to manage cholesterol levels and maintain long-term health, especially among middle-aged individuals.
Yahoo
01-05-2025
- Business
- Yahoo
Meiji, Lactalis, Saputo, Warburg may bid in Fonterra's $2.4 billion sale, sources say
By Kane Wu, Scott Murdoch and Yantoultra Ngui HONG KONG/SYDNEY (Reuters) -Companies including Japan's Meiji, French group Lactalis and Canada's Saputo are considering bidding for the units dairy giant Fonterra is seeking to divest, two sources with knowledge of the matter said this week. The companies would be bidding for Fonterra's global consumer businesses consisting of the operations and marketing of brands such as Mainland and Anchor butter, Kapiti ice cream and cheese and the Anlene powdered milk supplement. The sale also includes the Fonterra Oceania and Fonterra Sri Lanka units with operations from milk collection to processing to supplying products to consumers and food-service companies. A deal for the businesses Fonterra is divesting could be valued at around NZ$4 billion ($2.37 billion), the two sources said. U.S. private equity firm Warburg Pincus is also interested in buying the businesses, said one of the two sources and a third source with knowledge of Warburg's interest. New Zealand-based Fonterra announced in November a dual track plan to either sell the units or to list them through an initial public offering so it could focus on its core activity of processing milk at home. The company hopes to wrap up a sale by the middle of this year but is still looking at the IPO process, according to the first two sources. The three sources declined to be named as the matter was private. Fonterra said on Wednesday the process is confidential and cannot comment. Lactalis and Warburg Pincus declined to comment. Meiji said it is unable to make an official comment. Saputo did not respond to a request seeking comment. Fonterra is concurrently pressing ahead with IPO. In February, it named key management team members for the possible company, which it will name Mainland Group if the IPO route is chosen. Before making a final decision on a sale or IPO, the company plans to seek a vote from its farmer shareholders for their preferred divestment option. The operations being considered for a possible divestment accounted for about 19% of Fonterra's operating earnings in the first half of fiscal 2024, it said in May 2024. Shares of Fonterra have climbed 8% so far this year, giving it a market value of around $4.3 billion, LSEG data showed. The company's shares were down 0.2% on Thursday at NZ$4.53. ($1 = 1.6866 New Zealand dollars)
CNA
01-05-2025
- Business
- CNA
Meiji, Lactalis, Saputo, Warburg may bid in Fonterra's $2.4 billion sale, sources say
HONG KONG/SYDNEY :Companies including Japan's Meiji, French group Lactalis and Canada's Saputo are considering bidding for the units dairy giant Fonterra is seeking to divest, two sources with knowledge of the matter said this week. The companies would be bidding for Fonterra's global consumer businesses consisting of the operations and marketing of brands such as Mainland and Anchor butter, Kapiti ice cream and cheese and the Anlene powdered milk supplement. The sale also includes the Fonterra Oceania and Fonterra Sri Lanka units with operations from milk collection to processing to supplying products to consumers and food-service companies. A deal for the businesses Fonterra is divesting could be valued at around NZ$4 billion ($2.37 billion), the two sources said. U.S. private equity firm Warburg Pincus is also interested in buying the businesses, said one of the two sources and a third source with knowledge of Warburg's interest. New Zealand-based Fonterra announced in November a dual track plan to either sell the units or to list them through an initial public offering so it could focus on its core activity of processing milk at home. The company hopes to wrap up a sale by the middle of this year but is still looking at the IPO process, according to the first two sources. The three sources declined to be named as the matter was private. Fonterra said on Wednesday the process is confidential and cannot comment. Lactalis and Warburg Pincus declined to comment. Meiji said it is unable to make an official comment. Saputo did not respond to a request seeking comment. Fonterra is concurrently pressing ahead with IPO. In February, it named key management team members for the possible company, which it will name Mainland Group if the IPO route is chosen. Before making a final decision on a sale or IPO, the company plans to seek a vote from its farmer shareholders for their preferred divestment option. The operations being considered for a possible divestment accounted for about 19 per cent of Fonterra's operating earnings in the first half of fiscal 2024, it said in May 2024. Shares of Fonterra have climbed 8 per cent so far this year, giving it a market value of around $4.3 billion, LSEG data showed. The company's shares were down 0.2 per cent on Thursday at NZ$4.53. ($1 = 1.6866 New Zealand dollars)
